bf/NASDAQ:SAGE_icon.jpeg

NASDAQ:SAGE

Sage Therapeutics, Inc.

  • Stock

USD

Last Close

12.01

17/05 20:00

Market Cap

1.58B

Beta: 1.15

Volume Today

917.88K

Avg: 531.49K

PE Ratio

−2.29

PFCF: −2.65

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.09
-
0.01
93.31%
0.52
8,045.54%
0.00
99.33%
0.01
63.96%
0.10
1,629.37%
cash conversion cycle
-13.93K
-
-2.38K
82.88%
-18.04K
656.62%
-36.81K
104.03%
-1.17K
96.83%
cash per share
0.48
-
5.92
1,131.59%
6.72
13.52%
11.87
76.52%
13.61
14.71%
20.01
46.97%
19.84
0.85%
40.39
103.60%
29.70
26.47%
21.46
27.75%
12.59
41.34%
company equity multiplier
-0.27
-
1.06
493.21%
1.09
2.29%
1.10
0.87%
1.11
1.53%
1.10
0.95%
1.15
3.96%
1.04
9.21%
1.06
1.32%
1.08
2.58%
1.10
1.90%
days of inventory outstanding
-12.21K
-
-28.95K
137.02%
225.19
100.78%
days of payables outstanding
13.93K
-
2.38K
82.88%
6.90K
189.26%
8.51K
23.35%
1.74K
79.50%
days of sales outstanding
1.07K
-
648.70
39.42%
350.45
45.98%
dividend yield
ebit per revenue
-4.36
-
-103.10
2,266.91%
0.54
100.52%
-73.07
13,754.50%
-71.17
2.60%
-6.71
90.58%
ebt per ebit
1.00
-
1.00
0.17%
0.99
0.57%
0.99
0.38%
0.95
4.11%
0.96
1.31%
1.02
5.82%
0.99
2.27%
0.97
1.96%
0.93
4.13%
effective tax rate
0.00
-
0.00
77.69%
0.01
202.66%
0.01
43.20%
-0.05
506.23%
0.04
181.02%
0.03
42.12%
0.02
39.73%
0.06
259.06%
0.01
82.14%
enterprise value multiple
-27.25
-
-19.58
28.17%
-15.14
22.67%
-9.63
36.41%
-21.86
127.12%
-10.75
50.83%
-5.06
52.97%
4.39
186.93%
-4.82
209.60%
-3.86
19.86%
-2.41
37.68%
fixed asset turnover
11.27
-
0.16
98.58%
35.02
21,771.23%
0.33
99.06%
0.57
73.51%
13.55
2,268.17%
free cash flow per share
-1.04
-
-1.26
20.58%
-2.55
102.61%
-3.59
40.53%
-5.79
61.44%
-5.71
1.30%
-10.51
84.00%
12.77
221.48%
-6.45
150.52%
-7.77
20.47%
-9.04
16.35%
gross profit margin
1
-
0.94
5.82%
1.00
6.13%
0.91
8.72%
0.89
1.99%
0.98
9.04%
interest coverage
-4.23K
-
-38.55
-
inventory turnover
-0.03
-
-0.01
57.81%
1.62
12,956.52%
long term debt to capitalization
0.03
-
0.01
66.37%
0.01
32.19%
0.00
43.30%
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
0.96
4.42%
1
4.63%
0.98
1.54%
0.94
4.06%
1
5.87%
net profit margin
-4.13
-
-94.66
2,191.77%
0.54
100.57%
-71.47
13,238.82%
-65.48
8.38%
-6.26
90.43%
operating cash flow per share
-1.04
-
-1.25
20.04%
-2.54
103.00%
-3.54
39.26%
-5.75
62.37%
-5.65
1.76%
-10.40
84.02%
12.78
222.86%
-6.45
150.44%
-7.76
20.34%
-9.03
16.47%
operating cycle
-11.14K
-
-28.30K
153.98%
575.64
102.03%
operating profit margin
-4.36
-
-103.10
2,266.91%
0.54
100.52%
-73.07
13,754.50%
-71.17
2.60%
-6.71
90.58%
payables turnover
0.03
-
0.15
484.21%
0.05
65.43%
0.04
18.93%
0.21
387.73%
pretax profit margin
-4.13
-
-99.04
2,297.82%
0.54
100.55%
-72.59
13,444.72%
-69.32
4.51%
-6.26
90.96%
price fair value
-16.01
-
6.48
140.46%
9.32
43.92%
4.64
50.23%
13.20
184.51%
5.12
61.23%
3.88
24.12%
2.17
44.14%
1.44
33.48%
1.81
25.10%
1.62
10.19%
receivables turnover
0.34
-
0.56
65.07%
1.04
85.10%
return on assets
-2.14
-
-0.26
87.83%
-0.50
91.72%
-0.39
21.39%
-0.51
29.69%
-0.39
23.21%
-0.60
53.22%
0.28
146.81%
-0.25
187.99%
-0.37
50.22%
-0.61
65.42%
return on capital employed
-2.94
-
-0.28
90.57%
-0.54
96.47%
-0.43
20.42%
-0.57
31.79%
-0.45
20.60%
-0.73
60.56%
0.28
139.12%
-0.26
192.94%
-0.44
64.26%
-0.73
66.69%
return on equity
0.58
-
-0.28
147.85%
-0.54
96.12%
-0.43
20.70%
-0.57
31.68%
-0.43
23.94%
-0.69
59.28%
0.29
142.49%
-0.26
189.15%
-0.40
54.09%
-0.68
68.57%
total debt to capitalization
0.04
-
0.01
64.59%
0.01
21.16%
0.01
9.04%
0.01
33.10%

All numbers in USD (except ratios and percentages)